Alaunos Therapeutics Logo

Alaunos Therapeutics Logo (full size)

Alaunos Therapeutics Logo icon/symbol

Alaunos Therapeutics Logo (full size) on a dark background

Alaunos Therapeutics Logo icon/symbol on a dark background

About Alaunos Therapeutics

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.

Page last updated on:

calendar iconJuly 6th, 2024

Categories: